Greenwich Lifesciences Inc (GLSI) stock is higher by 11.51% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With GLSI Stock Today?
Greenwich Lifesciences Inc (GLSI) stock is down -7.86% while the S&P 500 has risen 0.56% as of 11:11 AM on Wednesday, Mar 10. GLSI has fallen -$2.57 from the previous closing price of $32.69 on volume of 211,551 shares. Over the past year the S&P 500 is higher by 20.04% while GLSI has fallen -82.86%. GLSI lost -$0.09 per share in the over the last 12 months.
To screen for more stocks like Greenwich Lifesciences Inc click here.
More About Greenwich Lifesciences Inc
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Click Here to get the full Stock Score Report on Greenwich Lifesciences Inc (GLSI) Stock.
